Some investigators reported better prognosis in certain cancers such as breast cancer with PIK3CA mutations, whereas others suggested that PIK3CA mutations indicated a worse prognosis in colorectal cancer, endometrial cancer and NSCLC [36], [37]. This evidence concerns the gene PIK3CA and cancer.